Alcon (ALC) Completes $550M Acquisition of Neurotech Pharmaceuticals
· gurufocus.com
On October 20, 2026, Alcon Inc (NYSE: ALC) announced the completion of its acquisition of Neurotech Pharmaceuticals for $550 million, securing control over Ence
On October 20, 2026, Alcon Inc (NYSE: ALC) announced the completion of its acquisition of Neurotech Pharmaceuticals for $550 million, securing control over Ence...